Savaliya BP, Shekouhi R, Mubarak F, Manaise HK, Jimenez PB, Kowkabany G, Popp RA, Popp K, Gabriel E. Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase-inhibitors. World J Gastroenterol 2024; 30(24): 3052-3058 [PMID: 38983963 DOI: 10.3748/wjg.v30.i24.3052]
Please LOGIN to submit a new comment.